PRX1 is frequently over-expressed in various cancer cells including lung, bladder, liver, thyroid, and breast cancers [22–24], and its over-expression has been associated with carcinogenesis, metastasis and resistance to radiotherapy or chemotherapy [22, 23, 25]. Here, PRDX1 is linked to cancer.